News | October 16, 2014

Imricor Medical Systems Announces License Agreement With Sorin Group

Focused on developing MRI conditional leads for cardiac rhythm management products

October 16, 2014 — Imricor Medical Systems Inc. announced that it has entered into a license agreement with Sorin Group to develop magnetic resonance imaging (MRI) compatible leads for use with Sorin implantable cardiac rhythm management devices.

"Imricor has unique knowledge and extensive expertise in the field of MRI compatible technology for implanted medical devices. By means of this agreement, we are working together to develop cardiac rhythm management products that can be used in MRI environments," said Stefano Di Lullo, president, cardiac rhythm management business unit, Sorin Group.

"We realize that many patients will benefit from the availability of MR conditional implanted devices, and Imricor's novel intellectual property can be applied to many of these devices. We look forward to working with Sorin Group to design MR conditional solutions for their cardiac rhythm management products that outperform anything currently on the market," said Steve Wedan, Imricor's president and CEO.

For more information: www.sorin.com, www.imricor.com


Additional Content

News | Magnetic Resonance Imaging (MRI)

Sept. 2, 2026 — Heartvue.ai and Innolitics have announced the U.S. Food and Drug Administration has granted 510(k) ...

Home September 04, 2026
Home
News | Magnetic Resonance Imaging (MRI)

Aug. 28, 2026 — Royal Philips and Imricor Medical Systems have announced a new Interventional MR (iMR) lab solution for ...

Home September 01, 2026
Home
News | Magnetic Resonance Imaging (MRI)

May 1, 2026 — Philips has received FDA 510(k) clearance for its Smart Fit TorsoCardiac 1.5T coil, a lightweight and ...

Home May 14, 2026
Home
News | Magnetic Resonance Imaging (MRI)

March 26, 2026 —The heart’s ability to use oxygen efficiently is a critical indicator of its health, but tests to ...

Home March 30, 2026
Home
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Home March 27, 2026
Home
Subscribe Now